ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

NUWE Newellis Inc

0,1705
-0,0355 (-17,23%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Newellis Inc NUWE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0355 -17,23% 0,1705 06:00:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,215 0,1674 0,232 0,18 0,206
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202415:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
01.5.202400:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
30.4.202422:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26.4.202415:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09.4.202415:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
11.3.202422:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202415:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
06.3.202418:02EDGAR2Form 8-K - Current report
05.3.202414:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05.3.202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
27.2.202415:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22.2.202413:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
20.2.202423:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
20.2.202414:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
08.2.202423:19EDGAR2Form S-1/A - General form for registration of securities..
06.2.202415:07EDGAR2Form 8-K - Current report
06.2.202415:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
09.1.202423:30EDGAR2Form 8-K/A - Current report: [Amend]
08.1.202415:24EDGAR2Form 8-K - Current report
04.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202421:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
13.12.202322:05EDGAR2Form 8-K - Current report
28.11.202314:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
14.11.202322:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
07.11.202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202314:15EDGAR2Form 8-K - Current report
07.11.202314:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
01.11.202321:15EDGAR2Form 8-K - Current report
01.11.202313:00GLOBENuwellis Announces Board of Directors Transition
31.10.202313:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
18.10.202322:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
17.10.202322:30EDGAR2Form 8-K - Current report
17.10.202322:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13.10.202314:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10.10.202314:30EDGAR2Form 8-K - Current report
10.10.202314:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
06.10.202322:50EDGAR2Form POS462C - Post-effective amendment to registration..
05.10.202315:27EDGAR2Form AW - Amendment Withdrawal Request
04.10.202323:29EDGAR2Form POS AM - Post-Effective amendments for registration..
02.10.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
29.9.202314:56EDGAR2Form S-1/A - General form for registration of securities..
11.9.202322:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
06.9.202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202322:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
18.8.202322:56EDGAR2Form 8-K - Current report
08.8.202318:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202314:25EDGAR2Form 8-K - Current report
08.8.202314:15EDGAR2Form 8-K - Current report
08.8.202314:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08.8.202314:00GLOBENuwellis Announces Plan for CFO Transition

Kürzlich von Ihnen besucht

Delayed Upgrade Clock